NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
15.16
+0.14 (0.93%)
At close: Jun 17, 2026, 4:00 PM EDT
15.46
+0.30 (1.98%)
After-hours: Jun 17, 2026, 6:32 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $516.86 million as of June 17, 2026. Its market cap has increased by 16.39% in one year.
Market Cap
516.86M
Enterprise Value
533.34M
1-Year Change
16.39%
Ranking
Category
Stock Price
$15.16
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $516.86M, an increase of 31.42%. That is a compound annual growth rate of 5.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 516.86M | 0.50% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SI-BONE | 683.87M |
| SS Innovations International | 672.44M |
| Beta Bionics | 647.48M |
| Tactile Systems Technology | 593.46M |
| BrainsWay | 593.13M |
| Cerus | 512.94M |
| Cytek Biosciences | 511.40M |
| Varex Imaging | 465.30M |